Antingenix America Overview

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 2

Antingenix America General Information

Description

Operator of immunology research reagents intended for use in biological, clinical, and laboratory-based studies of immune system function. The company's platform supplies antibody products, enzyme-linked immunosorbent assay components, multiplex assay systems, recombinant proteins, assay development materials, and related accessory, enabling biomedical research institutions, diagnostic laboratories, and life sciences organizations to conduct reproducible immunological analyses, develop assays, and support experimental validation across cytokine, cell marker, and immune signalling research.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • PO BOX 2666
  • Huntington Station
  • New York, NY 11746
  • United States
+1 (631)
Primary Industry
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • PO BOX 2666
  • Huntington Station
  • New York, NY 11746
  • United States
+1 (631)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Antingenix America Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 09-Jan-2026 Completed Generating Revenue
To view Antingenix America’s complete valuation and funding history, request access »

Antingenix America Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
New Jersey Commission on Science, Innovation and Technology Government Minority
Pier 70 Ventures Venture Capital Minority
To view Antingenix America’s complete investors history, request access »

Antingenix America FAQs

  • Where is Antingenix America headquartered?

    Antingenix America is headquartered in New York, NY.

  • What industry is Antingenix America in?

    Antingenix America’s primary industry is Discovery Tools (Healthcare).

  • Is Antingenix America a private or public company?

    Antingenix America is a Private company.

  • What is Antingenix America’s current revenue?

    The current revenue for Antingenix America is .

  • Who are Antingenix America’s investors?

    New Jersey Commission on Science, Innovation and Technology and Pier 70 Ventures have invested in Antingenix America.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process